A brief exposure to low levels of ethanol (10-50 mM) prior to cardiac ischemia reduces infarct size by ~60% in a process that is dependent on activation of epsilon protein kinase C, ePKC. We showed that activation of the mitochondrial enzyme, aldehyde dehydrogenase 2, ALDH2, is required and sufficient for ethanol-lnduced cardiac protection from ischemia;treatment with a novel activator of ALDH2 (Alda-1) mimics ethanol-lnduced cardioprotection. The importance of mitochondrial ALDH2 in human health is also suggested by the increased propensity of 40% of East Asians that carry an inactivating mutation in the ALDH2 gene, ALDH2*2, to have a variety of chronic diseases associated with oxidative stress and the resulting accumulation of toxic aldehydes, including myocardial infarction. In the next funding period, four aims will be addressed:
Aim 1 : Determine how ethanol-lnduced poundPKC-mediated activation of ALDH2 occurs. Mutagenesis and crystallographic studies, will help determine how ALDH2 phosphorylation enhances acetaldehyde catalysis.
Aim 2 : Determine if ethanol induces cardiac protection in ALDH2*2 mice from acute myocardial infarction, if ethanol-lnduced ePKC activation in these mice leads to phosphorylation of ALDH2*2 and if this phosphorylation increases the catalytic activity of the mutant enzyme Aim 3: Determine which proteins are modified by acetaldehyde and 4HNE and the functional consequence of these modifications.
Aim 4 : Identify pharmacological means to enhance aldehyde metabolism by changing the substrate preference of another ALDH enzyme. Together, these studies will elucidate fundamental processes associated with cytoprotection in animals with wild type and inactive (ALDH2*2) ALDH2 and how moderate ethanol exposure affects them. The proposed studies will also provide new tools and test their application as treatment for cardiac ischemia, using animal models.
(See Instmctions): This proposed study will identify the mechanism by which small amounts of ethanol activates a cellular mechanism that protects from tissue injury by heart attack. The information gained from this study will help design better drugs to activate this protective mechanism in the general populations and in about 40% of East Asians, in which this protective mechanism is defective.
|Zambelli, Vanessa O; Gross, Eric R; Chen, Che-Hong et al. (2014) Aldehyde dehydrogenase-2 regulates nociception in rodent models of acute inflammatory pain. Sci Transl Med 6:251ra118|
|Chen, Che-Hong; Ferreira, Julio Cesar Batista; Gross, Eric R et al. (2014) Targeting aldehyde dehydrogenase 2: new therapeutic opportunities. Physiol Rev 94:1-34|
|Ebert, Antje D; Kodo, Kazuki; Liang, Ping et al. (2014) Characterization of the molecular mechanisms underlying increased ischemic damage in the aldehyde dehydrogenase 2 genetic polymorphism using a human induced pluripotent stem cell model system. Sci Transl Med 6:255ra130|
|Solito, Raffaella; Corti, Federico; Chen, Che-Hong et al. (2013) Mitochondrial aldehyde dehydrogenase-2 activation prevents ýý-amyloid-induced endothelial cell dysfunction and restores angiogenesis. J Cell Sci 126:1952-61|
|Ferreira, Julio C B; Mochly-Rosen, Daria (2012) Nitroglycerin use in myocardial infarction patients. Circ J 76:15-21|
|Sun, Lihan; Ferreira, Julio Cesar Batista; Mochly-Rosen, Daria (2011) ALDH2 activator inhibits increased myocardial infarction injury by nitroglycerin tolerance. Sci Transl Med 3:107ra111|
|Banh, Alice; Xiao, Nan; Cao, Hongbin et al. (2011) A novel aldehyde dehydrogenase-3 activator leads to adult salivary stem cell enrichment in vivo. Clin Cancer Res 17:7265-72|
|Chen, Che-Hong; Sun, Lihan; Mochly-Rosen, Daria (2010) Mitochondrial aldehyde dehydrogenase and cardiac diseases. Cardiovasc Res 88:51-7|
|Koda, Kenichiro; Salazar-Rodriguez, Mariselis; Corti, Federico et al. (2010) Aldehyde dehydrogenase activation prevents reperfusion arrhythmias by inhibiting local renin release from cardiac mast cells. Circulation 122:771-81|
|Churchill, Eric N; Ferreira, Julio C; Brum, Patricia C et al. (2010) Ischaemic preconditioning improves proteasomal activity and increases the degradation of deltaPKC during reperfusion. Cardiovasc Res 85:385-94|
Showing the most recent 10 out of 12 publications